论文部分内容阅读
原发性肺癌(以下简称肺癌)是严重危害人民健康的常见恶性肿瘤,目前尚缺乏理想的诊断和治疗方法。沿用的X线和细胞学方法在早期诊断和鉴别诊断方面甚感不足,肺癌相关抗原的研究将有助于提高诊断率。自1968年Yachi开始对肺癌抗原进行研究以后,有些研究工作者用微量细胞毒、迟缓型超敏试验、白细胞移动抑制试验(LMI)、白细胞粘附抑制试验(LAI)等细胞免疫方法,证实肺癌组织于3M KCl提取液中存在
Primary lung cancer (hereinafter referred to as lung cancer) is a common malignancy that seriously jeopardizes people’s health. At present, there is a lack of ideal diagnosis and treatment methods. The X-ray and cytological methods used are very inadequate in early diagnosis and differential diagnosis. The study of lung cancer-associated antigens will help increase the diagnostic rate. Since Yachi began research on lung cancer antigens in 1968, some researchers have confirmed lung cancer using cellular immunoassay methods such as microcytotoxicity, delayed-type hypersensitivity testing, leukocyte migration inhibition test (LMI), and leukocyte adhesion inhibition test (LAI). Tissue present in 3M KCl extract